Revisions to Coumadin Labeling

New Coumadin Patient Medication Guide Available

If you are taking the drug Coumadin (warfarin) you are likely being followed very closely by your physician and pharmacist. The FDA (see Drug Safety Alerts and scroll down to Coumadin) and Bristol-Myers Squibb recently notified pharmacists and physicians of revisions to the labeling for Coumadin, to include a new patient Medication Guide as well as a reorganization and highlighting of the current safety information to better inform providers and patients.

FDA regulation requires that a Medication Guide be provided with each prescription that is dispensed for products that FDA determines pose a serious and significant public health concern. Information about all currently approved Medication Guides is available at http://www.fda.gov/cder/Offices/ODS/medication_guides.htm.